Abstract:

AIMS: The effective refractory period (ERP) is one of the main electrophysiological properties governing arrhythmia, yet ERP personalization is rarely performed when creating patient-specific computer models of the atria to inform clinical decision-making. This study evaluates the impact of integrating clinical ERP measurements into personalized in silico models on arrhythmia vulnerability. METHODS AND RESULTS: Clinical ERP measurements were obtained in seven patients from multiple locations in the atria. Atrial geometries from the electroanatomical mapping system were used to generate personalized anatomical atrial models. The Courtemanche M. et al. cellular model was adjusted to reproduce patient-specific ERP. Four modeling approaches were compared: homogeneous (A), heterogeneous (B), regional (C), and continuous (D) ERP distributions. Non-personalized approaches (A and B) were based on literature data, while personalized approaches (C and D) were based on patient measurements. Modeling effects were assessed on arrhythmia vulnerability and tachycardia cycle length, with sensitivity analysis on ERP measurement uncertainty. Mean vulnerability was 3.4 ± 4.0%, 7.7 ± 3.4%, 9.0 ± 5.1%, and 7.0 ± 3.6% for scenarios A-D, respectively. Mean tachycardia cycle length was 167.1 ± 12.6 ms, 158.4 ± 27.5 ms, 265.2 ± 39.9 ms, and 285.9 ± 77.3 ms for scenarios A-D, respectively. Incorporating perturbations to the measured ERP in the range of 2, 5, 10, 20, and 50 ms changed the vulnerability of the model to 5.8 ± 2.7%, 6.1 ± 3.5%, 6.9 ± 3.7%, 5.2 ± 3.5%, and 9.7 ± 10.0%, respectively. CONCLUSION: Increased ERP dispersion had a greater effect on re-entry dynamics than on vulnerability. Inducibility was higher in personalized scenarios compared with scenarios with uniformly reduced ERP; however, this effect was reversed when incorporating fibrosis informed by low-voltage areas. Effective refractory period measurement uncertainty up to 20 ms slightly influenced vulnerability. Electrophysiological personalization of atrial in silico models appears essential and requires confirmation in larger cohorts.

Abstract:

Lernende Systeme oder Machine Learning, so sind sich Fachleute einig, werden auch in der Medizin und der Medizintechnik zukünftig eine große Bedeutung erlangen – mit Vorteilen aber auch mit Risiken für Patientinnen und Patienten, Unternehmen und Fachpersonal. Dabei ergeben sich verschiedenste Herausforderungen im Umgang mit Machine-Learning-Systemen – unter anderem für praktische Behandlungssituationen, für die Qualitätskontrolle, für die Sicherheit in Notfallsituationen oder die Bewertung der vom Computer vorgeschlagenen Diagnosen und Therapiepfade. Die vorliegende acatech POSITION ist das Ergebnis einer Arbeitsgruppe von Wissenschaftlerinnen und Wissenschaftlern aus Medizin und Technik. Die Projektgruppe gibt einen Überblick über heutige Anwendungen von Machine Learning in der Medizintechnik und beleuchtet wichtige zukünftige Anwendungsfelder. Im Fokus stehen darüber hinaus ethische, rechtliche und regulatorische Aspekte sowie kritische Fragen zum Datenschutz und mögliche Veränderungen im Arzt-Patienten-Verhältnis. Neben Vorschlägen zum Aufbau großer medizinischer Datenbanken gibt diese Position auch Handlungsempfehlungen für Ärztinnen und Ärzte, Einrichtungen der Forschungsförderung und die Politik.

Abstract:

Atrial fibrillation (AF) is the most common sus- tained arrhythmia posing a significant burden to patients and leading to an increased risk of stroke and heart failure. Additional ablation of areas of arrhythmogenic substrate in the atrial body detected by either late gadolinium enhance- ment magnetic resonance imaging (LGE-MRI) or electro- anatomical mapping (EAM) may increase the success rate of restoring and maintaining sinus rhythm compared to the stan- dard treatment procedure of pulmonary vein isolation (PVI). To evaluate if LGE-MRI and EAM identify equivalent sub- strate as potential ablation targets, we divided the left atrium (LA) into six clinically important regions in ten patients. Then, we computed the correlation between both modalities by ana- lyzing the regional extents of identified pathological tissue. In this regional analysis, we observed no correlation between late gadolinium enhancement (LGE) and low voltage areas (LVA), neither in any region nor with regard to the entire atrial surface (−0.3 < 𝑟 < 0.3). Instead, the regional extents identified as pathological tissue varied significantly between both modali- ties. An increased extent of LVA compared to LGE was ob- served in the septal wall of the LA (𝑎 ̃sept.,LVA = 19.63 % and 𝑎 ̃sept.,LGE = 3.94 %, with 𝑎 ̃ = median of the extent of patho- logical tissue in the corresponding region). In contrast, in the inferior and lateral wall, the extent of LGE was higher than the extent of LVA for most geometries (𝑎 ̃inf.,LGE = 27.22% and 𝑎 ̃lat.,LGE = 32.70 % compared to 𝑎 ̃inf .,LVA = 9.21 % and 𝑎 ̃lat.,LVA = 6.69 %). Since both modalities provided dis- crepant results regarding the detection of arrhythmogenic sub- strate using clinically established thresholds, further investiga- tions regarding their constraints need to be performed in order to use these modalities for patient stratification and treatment planning.

Abstract:

Introduction: Although the effective refractory period (ERP) is one of the main electrophysiological properties governing atrial tachycardia (AT) maintenance, ERP personalization is rarely performed when creating patient-specifi c computer models of the atria to inform clinical decision-making. State-of-the-art models usually do not consider physiological ERP gradients but assume a homogeneous ERP distribution. This assumption might have an influence on the ability to induce reentries in the model.Aim: To evaluate the impact of incorporating clinical ERP measurements when creating in silico personalized models to predict vulnerability to atrial fibrillation (AF).Methods: Clinical ERP measurements were obtained from three patients from multiple locations in the atria. The protocol for ERP identification consisted of trains of 7 S1 stimuli with a basic cycle length of 500ms followed by an S2 stimulus with a coupling interval between 300 and 200ms in decrements of 10ms until loss of capture. The atrial geometries from the electroanatomical mapping system were used to generate personalized atrial models. To reproduce patient-specific ERP, the established Courtemanche cellular model was gradually reparameterized from control conditions to a setup representing AF-induced remodeling. Three different approaches were studied:1) a control scenario with no ERP personalization 2) a discrete split where each region had a single ERP value and3) a continuous ERP distribution by interpolation of measured ERP data (Fig. 1). Arrhythmia vulnerability was assessed by virtual S1S2 pacing from different locations separated by 3cm. The number and location of inducing points and type of arrhythmia were determined for the three approaches. The mean conduction velocity was setto 0.7 m/s and the electrical propagation in the atria was modeled by the monodomain equation and solved withopenCARP.Results: Incorporating patient-specific ERP as a continuous distribution did not induce any reentrant activity. A summary of induced ATs is shown in Table 1. For patient A, AF was induced from 3 different locations with the control setup, whereas 9 ATs were induced with the regional method, of which 4 were AF and 5 macro reentries. For patient B, AF was induced from 1 point with the control setup; whereas with the regional approach, AF was induced at 4 points. For patient C, only one macro reentry was induced with the regional method.Conclusion: The incorporation of patient-specifi c ERP values has an impact on the assessment of AF vulnerability. Furthermore, the type of personalization affects the likelihood of AF inducibility. The incorporation of more detailed ERP distributions may lead to a more accurate prediction of AF trigger points and could in the future inform patient-specifi c therapy planning. Larger cohorts need to follow to demonstrate the role of incorporating clinical patient-specifi c ERP values into personalized models for predicting AF vulnerability.

Abstract:

Atrial fibrillation (AF) is the most common arrhythmia posing a significant burden to patients and leading to an increased risk of stroke and heart failure. However, the underlying mechanisms of AF are still not entirely understood. While the general treatment of pulmonary vein isolation (PVI) is an effective therapy for patients with paroxysmal AF, the success rate for maintaining sinus rhythm significantly decreases for individuals with persistent AF. It has been reported that this may be due to non-PVI triggers in the atrial body of patients with persistent AF in combination with the presence of structural remodeling processes. Thus, individual treatment strategies need to be elaborated which require regional examinations of the atria. However, since there is no consensus regarding the atrial region division, intra- and inter-, as well as cross-modality quantitative comparisons cannot be performed.To address this challenge, a bi-atrial standard nomenclature with six regions for each atrium was established by considering multiple acquisition modalities and previous approaches proposed in the literature. Furthermore, a robust semi-automatic bi-atrial division pipeline with consistent and reproducible region assignment was developed. This algorithm was tested on 15 bi-atrial and 10 additional left atrial geometries from three independent data sets with multiple acquisition modalities. The results showed qualitative and quantitative accordance with the introduced standard nomenclature, while offering a high degree of autonomy and reproducibility. User intervention was required in 2.7 % of all region assignments.In addition, the atrial division pipeline was used to regionally analyze clinical data of electroanatomical mapping (EAM) and late gadolinium enhancement magnetic resonance imaging (LGE-MRI), which are commonly used modalities to detect arrhythmogenic substrate. However, no accordance was found between late gadolinium enhancement (LGE) and low voltage area (LVA). Instead, the regional extent and spatial distribution of identified pathological tissue varied significantly between both modalities. Moreover, an increased extent of LVA compared to LGE was observed in the septal wall of the left atrium (LA) in two independent data sets. In contrast, LGE was predominantly detected in the lateral wall of the LA. However, these findings need to be investigated further, since the analyzed data set of 12 patients in total was comparatively small.This work provides a unified framework to regionally compare and integrate data from different fields such as research, clinics and technology to further understand the underlying mechanisms of AF and to personalize the treatment strategies.